We enable gastroenterologists to make treatment decisions in less than 5 minutes and without compromising lab-quality results.
Great improvements in therapy of Inflammatory Bowel diseases have been made for patients and especially with the rise of TNFα.
Studies and key opinion leaders agree that physicians should consistently monitor these therapeutic treatments to achieve the best results.
Our drug monitoring assays will provide you results from fingerprick whole blood in less than 5 minutes enabling decisions at time of treatment.
Easy.
A finger-prick sample and minimal staff training is all you need.
Immediate.
Total turnaround time is only 2 to 5 minutes. Every minute matters during a patient appointment or pharmacy visit. 10, 15, 20 minutes? That’s not point-of-care.
Accurate.
Central-lab quality, sensitivity and specificity.
Healthcare professionals are not willing to give up lab-quality results to point-of-care.
Lab-quality answers. In-office easy.
Welcome to immediate clinical decisions during visits.
Meet ProciseDx, your new partner for point-of-care solutions. Our platform is optimized for quantitative immunoassays, making it simple to get lab quality results - in real time, right in your office. Leveraging proven technology and patented chemistry, we’re delivering diagnostic answers that allow immediate actions. It’s a new normal that makes patient visits more productive than ever, and turn any site into a powerhouse for patient care.
“With ProciseDx, we will be able to measure levels of infliximab and adalimumab in five minutes from fingerstick blood. This information during the patient visit will be incorporated into our immediate treatment decisions.”
— Geert D’Haens, Professor of Gastroenterology at the AMC & Director of European Operations at Robarts Clinical Trials
Contact Us
To stay informed about our company, or to speak with our team, please contact us here or email info@procisediagnostics.com.